A retrospective study of intravenous pentamidine for Pneumocystis jirovecii pneumonia prophylaxis in adult patients with hematologic malignancies—its utility during respiratory virus pandemics

• Published in: International journal of infectious diseases Vol. 143; p. 107059
• Main Authors: Liew, Yi Xin, Ho, Aloysius Yew Leng, Wong, Gee Chuan, Chung, Shimin Jasmine, Tan, Thuan Tong, Tan, Ban Hock
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01.06.2024; Elsevier
• Subjects: PCP prophylaxis; Pentamidine; Pentamidine; PCP prophylaxis

•In hematology, Pneumocystis jirovecii pneumonia prophylaxis is recommended for selected patients.•Intravenous pentamidine is a potential alternative agent.•A total of 202 unique patients received 239 courses of intravenous pentamidine 4 mg/kg (maximum 300 mg).•There was no breakthrough P. jirovecii...